Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmanex does not market lovastatin in guise of dietary supplement -- company to FDA.

This article was originally published in The Tan Sheet

Executive Summary

PHARMANEX IS NOT MARKETING LOVASTATIN in the guise of a dietary supplement as Cholestin, the company asserts in an Oct. 29 filing with FDA. "Rather, Cholestin is a natural dietary supplement composed entirely of red yeast rice made by the traditional Chinese method," the company maintains. "Many of these traditional red yeast rice products naturally contain a range of HMG-CoA reductase inhibitors -- including mevinolin (which the agency equates chemically with lovastatin) -- as well as unsaturated fatty acids" and other constituents which contribute to the product's "functionality," Pharmanex states.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel